PubRank

J A Staessen

Author PubWeight™ 92.85‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998 6.20
2 Immediate and late benefits of treating very elderly people with hypertension: results from active treatment extension to Hypertension in the Very Elderly randomised controlled trial. BMJ 2011 2.77
3 European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens 2010 2.06
4 Reference values for self-recorded blood pressure: a meta-analysis of summary data. Arch Intern Med 1998 2.01
5 Influence of the presence of doctors-in-training on the blood pressure of patients: a randomised controlled trial in 22 teaching practices. J Hum Hypertens 2004 1.99
6 What is "hypertension"? Lancet 1999 1.99
7 Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch Intern Med 2000 1.99
8 Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation 2000 1.98
9 Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group. J Hypertens 1998 1.83
10 Blood pressure, cognitive functions, and prevention of dementias in older patients with hypertension. Arch Intern Med 2001 1.77
11 Chinese trial on isolated systolic hypertension in the elderly. Systolic Hypertension in China (Syst-China) Collaborative Group. Arch Intern Med 2000 1.69
12 Autonomic nervous function, arterial stiffness and blood pressure in patients with Type I diabetes mellitus and normal urinary albumin excretion. J Hum Hypertens 2004 1.51
13 Effect of age on brachial artery wall properties differs from the aorta and is gender dependent: a population study. Hypertension 2000 1.48
14 The relationships between left ventricular mass and daytime and night-time blood pressures: a meta-analysis of comparative studies. J Hypertens 1995 1.45
15 Night-day blood pressure ratio and dipping pattern as predictors of death and cardiovascular events in hypertension. J Hum Hypertens 2009 1.42
16 An epidemiological re-appraisal of the association between blood pressure and blood lead: a meta-analysis. J Hum Hypertens 2002 1.40
17 [Cognitive impairment and dementia in hypertension; the effect of antihypertensive medication]. Ned Tijdschr Geneeskd 2000 1.38
18 Non-invasive assessment of local arterial pulse pressure: comparison of applanation tonometry and echo-tracking. J Hypertens 2001 1.25
19 Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension. Hypertension 2001 1.19
20 Should exercise blood pressure be measured in clinical practice? J Hypertens 1998 1.08
21 The pulse pressure-to-stroke index ratio predicts cardiovascular events and death in uncomplicated hypertension. J Am Coll Cardiol 2001 1.06
22 Advantages and disadvantages of the meta-analysis approach. J Hypertens Suppl 1996 1.05
23 Independent prognostic value of the ambulatory arterial stiffness index and aortic pulse wave velocity in a general population. J Hum Hypertens 2007 1.04
24 Genetic polymorphisms in the renin-angiotensin system: relevance for susceptibility to cardiovascular disease. Eur J Pharmacol 2000 1.04
25 The international database of self-recorded blood pressures in normotensive and untreated hypertensive subjects. Blood Press Monit 1999 1.03
26 Properly defining white coat hypertension. Eur Heart J 2002 1.00
27 Ambulatory blood pressure of adults in Novosibirsk, Russia: interim report on a population study. Blood Press Monit 2001 0.98
28 Prediction of cardiac structure and function by repeated clinic and ambulatory blood pressure. Hypertension 1997 0.97
29 The relationship between blood pressure and blood lead in NHANES III. National Health and Nutritional Examination Survey. J Hum Hypertens 2002 0.97
30 Impact of environmental cadmium pollution on cadmium exposure and body burden. Arch Environ Health 1992 0.93
31 Carotid and femoral artery stiffness in relation to three candidate genes in a white population. Hypertension 2001 0.93
32 Cerebral complications of hypertension. J Hum Hypertens 2001 0.93
33 Arterial structure and function and environmental exposure to cadmium. Occup Environ Med 2007 0.91
34 For how many days should blood pressure be measured at home in older patients before steady levels are obtained? J Hum Hypertens 1997 0.90
35 Treatment of isolated systolic hypertension in the elderly: the Syst-Eur trial. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Clin Exp Hypertens 1999 0.90
36 Prognostic value of invasive hemodynamic measurements at rest and during exercise in hypertensive men. Hypertension 1996 0.89
37 Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. J Hypertens 2001 0.89
38 Efficacy of different drug classes used to initiate antihypertensive treatment in black subjects: results of a randomized trial in Johannesburg, South Africa. Arch Intern Med 2001 0.88
39 Influence of demographic, anthropometric and lifestyle characteristics on heart rate and its variability in the population. J Hypertens 1999 0.88
40 Intracellular concentration and transmembrane fluxes of sodium and potassium in erythrocytes of white normal male subjects with and without a family history of hypertension. J Hypertens 1984 0.85
41 Correlates of cognitive status of old patients with isolated systolic hypertension: the Syst-Eur Vascular Dementia Project. J Hypertens 1998 0.85
42 Renal function in relation to three candidate genes. Am J Kidney Dis 2001 0.83
43 Relationships between changes in left ventricular mass and in clinic and ambulatory blood pressure in response to antihypertensive therapy. J Hypertens 1997 0.82
44 Power spectral analysis of heart rate variability by autoregressive modelling and fast Fourier transform: a comparative study. Acta Cardiol 1998 0.82
45 Should pulse pressure become part of the Framingham risk score? J Hum Hypertens 2004 0.81
46 Associations of orthostatic blood pressure fall in older patients with isolated systolic hypertension. Syst-Eur Investigators. J Hypertens 1996 0.81
47 Trough-to-peak versus surface ratio in the assessment of antihypertensive agents. APTH Investigators. Ambulatory Blood Pressure and Treatment of Hypertension. Blood Press 1995 0.81
48 Ambulatory blood pressure and left ventricular structure and function in relation to the G-protein beta3-subunit polymorphism C825T in White Europeans. J Hum Hypertens 2003 0.81
49 Antihypertensive treatment modulates the association between the D/I ACE gene polymorphism and left ventricular hypertrophy: a meta-analysis. J Hum Hypertens 2000 0.80
50 Does B-mode common carotid artery intima-media thickness differ from M-model? Ultrasound Med Biol 2001 0.80
51 Systolic Hypertension in Europe (Syst-Eur) trial phase 2: objectives, protocol, and initial progress. Systolic Hypertension in Europe Investigators. J Hum Hypertens 1999 0.80
52 Efficacy of newer versus older antihypertensive drugs in black patients living in sub-Saharan Africa. J Hum Hypertens 2013 0.80
53 Effects of antihypertensive treatment on endpoints in the diabetic patients randomized in the Systolic Hypertension in Europe (Syst-Eur) trial. J Nephrol 2000 0.80
54 Symptoms reported by elderly patients with isolated systolic hypertension: baseline data from the SYST-EUR trial. Systolic Hypertension in Europe. Age Ageing 1999 0.80
55 Risks of smoking in treated and untreated older Chinese patients with isolated systolic hypertension. J Hypertens 2001 0.80
56 Blood pressure and urinary sodium excretion in relation to the A-1984G adrenomedullin polymorphism in a Chinese population. Kidney Int 2006 0.79
57 Context-dependency of the relation between left ventricular mass and AGT gene variants. J Hum Hypertens 2005 0.79
58 Dementia and statins. Lancet 2001 0.79
59 1A.04: CORRELATES OF PERIPHERAL BLOOD MITOCHONDRIAL DNA COPY NUMBER IN A GENERAL POPULATION. J Hypertens 2015 0.79
60 6C.05: STK39 AND WNK1 ARE POTENTIAL HYPERTENSION SUSCEPTIBILITY GENES IN THE BELHYPGEN COHORT. J Hypertens 2015 0.79
61 Ambulatory blood pressure monitoring and postprandial hypotension in elderly patients with isolated systolic hypertension. Systolic Hypertension in Europe (SYST-EUR) Trial Investigators. J Hum Hypertens 1998 0.79
62 3C.09: STRATEGIES FOR CLASSIFYING PATIENTS BASED ON OFFICE, HOME AND AMBULATORY BLOOD PRESSURE MEASUREMENT. J Hypertens 2015 0.78
63 Prevalence and persistency of orthostatic blood pressure fall in older patients with isolated systolic hypertension. Syst-Eur Investigators. J Hum Hypertens 1996 0.78
64 Relationships of heart rate and heart rate variability with conventional and ambulatory blood pressure in the population. J Hypertens 2001 0.77
65 Hypertension Optimal Treatment (HOT) trial. Lancet 1998 0.77
66 Intra-erythrocyte cation concentrations in relation to the C1797T beta-adducin polymorphism in a general population. J Hum Hypertens 2007 0.77
67 Blood pressure and dementia. Panminerva Med 2004 0.77
68 8B.01: META-ANALYSIS OF FIVE PROSPECTIVE AND RANDOMIZED CONTROLLED TRIALS OF RENAL SYMPATHETIC DENERVATION ON OFFICE AND AMBULATORY SYSTOLIC BLOOD PRESSURE IN TREATMENT RESISTANT HYPERTENSION. J Hypertens 2015 0.77
69 Blood pressure-measuring devices: time to open Pandora's box and regulate. Hypertension 2000 0.76
70 [Treatment of isolated systolic arterial hypertension and prevention of dementia in aged patients. The Syst-Eur multicenter study]. Arch Mal Coeur Vaiss 1999 0.76
71 Arterial properties in relation to genetic variation in alpha-adducin and the renin-angiotensin system in a White population. J Hum Hypertens 2008 0.76
72 A plea for harmonising guidelines. Int J Cardiol 2001 0.76
73 Detection of cerebral aging, an absolute need: predictive value of cognitive status. Eur Neurol 1998 0.76
74 Blood pressure, cardiovascular outcomes and sodium intake, a critical review of the evidence. Acta Clin Belg 2013 0.76
75 Renal artery stenosis: evaluation with intravenous digital subtraction angiography. Radiology 1986 0.76
76 Critical appraisal of the JNC VI, WHO/ISH and BHS guidelines for essential hypertension. Expert Opin Pharmacother 2000 0.76
77 Short report: low-level lead exposure does not increase the blood pressure in the general population. Cadmibel Study Group. J Hypertens 1993 0.76
78 Definition of new targets in cardiovascular prevention from young into old age. Eur Heart J 2002 0.75
79 Inverse association between baseline pressure and benefit from treatment in isolated systolic hypertension. Hypertension 1994 0.75
80 What does STOP-2 tell us about management of hypertension? Lancet 2000 0.75
81 Blood pressure in very old subjects: a dilemma for the clinician. Eur Heart J 1998 0.75
82 Hypertension and lead exposure. JAMA 1996 0.75
83 Antihypertensive drugs and cognitive function in older people. J Am Geriatr Soc 1998 0.75
84 1D.03: INACTIVE MATRIX GLA PROTEIN IS ASSOCIATED WITH RENAL RESISTIVE INDEX IN A POPULATION-BASED STUDY. J Hypertens 2015 0.75
85 Participation rate in the Belgian population study on ambulatory blood pressure monitoring. J Hypertens 1996 0.75
86 Antiproteinuric effects of cilnidipine. Kidney Int 2008 0.75
87 Antihypertensive drug therapy in older patients. Curr Opin Nephrol Hypertens 2001 0.75
88 5C.09: HERITABILITY OF RENAL FUNCTION PARAMETERS AND ELECTROLYTE LEVELS IN THE SWISS POPULATION. J Hypertens 2015 0.75
89 Benefit of antihypertensive treatment in the diabetic patients enrolled in the Systolic Hypertension in Europe (Syst-Eur) trial. Cardiovasc Drugs Ther 2000 0.75
90 8A.02: THE ASSOCIATION OF LEFT VENTRICULAR AND ATRIAL STRUCTURE WITH BODY COMPOSITION: IMPACT AND PITFALLS OF SCALING IN POPULATION BASED STUDIES. J Hypertens 2015 0.75
91 Therapy in old patients with isolated systolic hypertension: fourth progress report on the Syst-Eur trial. J Hum Hypertens 1997 0.75
92 Implications of the Systolic Hypertension in Europe (Syst-Eur) Trial for clinical practice. Nephrol Dial Transplant 1997 0.75
93 The benefit of treating isolated systolic hypertension. Curr Hypertens Rep 2001 0.75
94 [OP.4B.04] LONGITUDINAL CHANGES IN LEFT VENTRICULAR STRUCTURE AND DIASTOLIC FUNCTION IN RELATION TO ARTERIAL PROPERTIES IN A GENERAL POPULATION. J Hypertens 2016 0.75
95 [OP.1B.01] VITAMIN K DEPENDENT PROTECTION OF RENAL FUNCTION IN MULTI-ETHNIC POPULATION STUDIES. J Hypertens 2016 0.75
96 Clinical trials in isolated systolic hypertension. Curr Hypertens Rep 1999 0.75
97 Short-term morphologic results of percutaneous transluminal renal angioplasty as determined with angiography. Radiology 1989 0.75
98 Genetic variation and environmental factors in biological and arterial ageing. Verh K Acad Geneeskd Belg 2008 0.75
99 Ambulatory blood pressure monitoring in clinical trials. Ann N Y Acad Sci 1996 0.75
100 Interaction between nonsteroidal anti-inflammatory drug intake and calcium-channel blocker-based antihypertensive treatment in the Syst-Eur trial. J Hum Hypertens 2001 0.75
101 Normality of ambulatory blood pressure. Blood Press Monit 1999 0.75
102 [OP.7D.07] INFLUENCE OF RENAL SYMPATHETIC DENERVATION ON BLOOD PRESSURE VARIABILITY: EXPERIENCE AT 11 EUROPEAN EXPERT CENTERS. J Hypertens 2016 0.75
103 Ambulatory and conventional pulse pressures and mean pressures as determinants of the Sokolow-Lyon ECG voltage index in older patients with systolic hypertension. Blood Press Monit 2001 0.75
104 Risk and benefit of treatment of isolated systolic hypertension in the elderly: evidence from the Systolic Hypertension in Europe Trial. Curr Opin Cardiol 2001 0.75
105 [OP.1A.10] CONVENTIONAL AND AMBULATORY BLOOD PRESSURE AS PREDICTORS OF RETINAL ARTERIOLAR NARROWING. J Hypertens 2016 0.75
106 Improved outcomes with antihypertensive medication in the elderly with isolated systolic hypertension. Drugs Aging 2001 0.75
107 Relationship between systemic haemodynamics and glucose tolerance in patients with essential hypertension. J Hypertens Suppl 1991 0.75
108 1C.06: AMBULATORY PULSE PRESSURE IS NEGATIVELY ASSOCIATED WITH EXCRETIONS OF URINARY CAFFEINE AND ITS METABOLITES. J Hypertens 2015 0.75
109 Treatment of diabetic patients with hypertension. Curr Hypertens Rep 1999 0.75
110 [OP.1B.10] RISK SCORE FOR INCIDENT HEART FAILURE: A SUBJECT-LEVEL META-ANALYSIS FROM THE HEART 'OMICS' IN AGEING (HOMAGE) DATABASE. J Hypertens 2016 0.75
111 [Hypertension as a source of cognitive regression, or dementia]. Ned Tijdschr Geneeskd 2007 0.75
112 [OP.7C.07] DIASTOLIC LEFT VENTRICULAR FUNCTION IN RELATION TO COLLAGEN-SPECIFIC URINARY AND SERUM COLLAGEN BIOMARKERS IN A GENERAL POPULATION. J Hypertens 2016 0.75
113 Diagnosis and treatment of hypertensive disorders during pregnancy. Acta Clin Belg 2010 0.75
114 [Syst-Eur study: analysis of the benefits of nitrendipine in hypertensive type 2 diabetics]. Arch Mal Coeur Vaiss 2003 0.75
115 Treatment of hypertensive patients according to the conventional or ambulatory pressure: a progress report on the APTH trial. APTH Investigators. Ambulatory Blood Pressure and Treatment of Hypertension. Acta Cardiol 1996 0.75
116 5B.02: LONGITUDINAL CHANGES IN LEFT VENTRICULAR DIASTOLIC FUNCTION IN A GENERAL POPULATION. J Hypertens 2015 0.75
117 Benefits of antihypertensive drug treatment in elderly patients with isolated systolic hypertension. Neth J Med 2001 0.75
118 Implications of the Systolic Hypertension in China trial. Clin Exp Hypertens 1999 0.75
119 Blood pressure measurement in the year 2008: revival of oscillometry? Neth J Med 2008 0.75